melphalantopotecanTPTTPT-relatedretinoblastoma
…etinoblastoma over the last few years. Due to rapid hydrolysis, melphalan must be administered within the hour following reconstitution. …
7articles mentioning drugs
9drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: melphalan ×
melphalan
This drug is selected. Its supporting articles are shown below.
Articles mentioning melphalan
7 articles · page 1 of 1melphalantopotecancarboplatinretinoblastomaRbthree-drug regimen IACtwo-drug regimen IACintra-arterial chemotherapy
…n (melphalan, topotecan and carboplatin) with two-drug regimen (melphalan and topotecan) on the globe salvage outcomes of retinoblastoma …
daratumumablenalidomidebortezomibmelphalanprednisonedexamethasoneDaratumumab-basedD-VMPD-VCPD-Rd+4 more
…s conducted including NDMM patients aged ≥80 years treated with daratumumab from its introduction until January 2025. Baseline variables in…
melphalanUveal melanomaimmunotherapies
…metastases of uveal melanoma. Preconditioning chemotherapy with melphalan (1 mg/kg, intravenous) was administered on day −5. TILs were de…
topotecanmelphalanRBphthisis bulbiintra-arterial chemotherapyretinoblastoma
…/or intra-arterial chemotherapy. Patients received intravitreal topotecan (30 µg/0.1 mL) and/or intravitreal melphalan (20–30 µg/0.1 mL) …
melphalanretinoblastomaIntra-arterial chemotherapyIAC
…solve. Persistent NP can be related to high cumulative doses of melphalan, administered in attempt to target refractory tumour control.…
melphalantumor necrosis factor-alphatalimogene laherparepvecmelanomasarcoma
…ic herpes simplex virus, talimogene laherparepvec (T-VEC), with melphalan and tumor necrosis factor-alpha delivered by ILP, in patients w…